68 results
D
CRNX
Crinetics Pharmaceuticals Inc
11 Mar 24
$350.00 mm in equity, sold $350.00 mm, 36 investors
4:15pm
of this Form D are "covered securities" for purposes
of NSMIA, whether in all instances or due to the nature of the offering that is the subject
8-K
EX-10.1
CRNX
Crinetics Pharmaceuticals Inc
1 Mar 24
Crinetics Pharmaceuticals Announces Oversubscribed $350 Million Private Placement
4:07pm
. The Company agrees to indemnify and to hold harmless the Purchasers from any liability for any commission or compensation in the nature of a finder’s … or such enforcement or setoff had not occurred.
7.16 Independent Nature of Purchasers’ Obligations and Rights. The obligations of each Purchaser under
8-K
EX-10.2
CRNX
Crinetics Pharmaceuticals Inc
1 Mar 24
Crinetics Pharmaceuticals Announces Oversubscribed $350 Million Private Placement
4:07pm
Independent Nature of Holders’ Obligations and Rights. The obligations of each Holder hereunder are several and not joint with the obligations of any … the registered broker-dealer(s), describe the nature of the affiliation(s) and answer subsection (a) and subsection (b):
Did the Selling
8-K
EX-99.2
hilfg0
11 Sep 23
Regulation FD Disclosure
6:05am
UPLOAD
faev55
20 Dec 22
Letter from SEC
12:00am